Quick Answer
NANOVIRICIDES, INC. reported Operating Income Loss of -$9.59 million for the year ending 2025.
- NANOVIRICIDES, INC. showed a decrease of -12.6% in Operating Income Loss from 2024 to 2025.
- This data is from NANOVIRICIDES, INC.'s annual report (Form 10-K), filed with the SEC on September 29, 2025.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2010: -$1.50 million | Q1 2011: -$2.56 million | Q3 2011: -$1.14 million | Q4 2011: -$1.34 million | Q1 2012: -$2.08 million | Q3 2012: -$1.59 million | Q4 2012: -$1.24 million | Q1 2013: -$2.19 million | Q3 2013: -$1.89 million | Q4 2013: -$1.75 million | Q1 2014: -$1.23 million | Q3 2014: -$1.69 million | Q4 2014: -$1.70 million | Q1 2015: -$1.12 million | Q3 2015: -$2.23 million | Q4 2015: -$2.09 million | Q1 2016: -$2.05 million | Q3 2016: -$2.44 million | Q4 2016: -$2.30 million | Q1 2017: -$2.62 million | Q3 2017: -$2.23 million | Q4 2017: -$2.39 million | Q1 2018: -$2.42 million | Q3 2018: -$2.04 million | Q4 2018: -$2.37 million | Q1 2019: -$2.08 million | Q3 2019: -$1.99 million | Q4 2019: -$1.63 million | Q1 2020: -$2.54 million | Q3 2020: -$2.27 million | Q4 2020: -$2.29 million | Q1 2021: -$2.11 million | Q3 2021: -$2.61 million | Q4 2021: -$1.92 million | Q1 2022: -$1.79 million | Q3 2022: -$1.62 million | Q4 2022: -$1.83 million | Q1 2023: -$1.81 million | Q3 2023: -$2.03 million | Q4 2023: -$2.18 million | Q1 2024: -$1.91 million | Q3 2024: -$3.17 million | Q4 2024: -$2.06 million | Q1 2025: -$2.25 million | Q3 2025: -$1.80 million | Q4 2025: -$2.23 million.
- Over the full 13 years of available data (2013 to 2025), NANOVIRICIDES, INC.'s Operating Income Loss has declined by 45.5%.
- Historical annual values: Fiscal year 2025: -$9.59 million | Fiscal year 2024: -$8.52 million | Fiscal year 2023: -$8.94 million | Fiscal year 2022: -$8.11 million | Fiscal year 2021: -$8.74 million | Fiscal year 2020: -$8.00 million | Fiscal year 2019: -$8.66 million | Fiscal year 2018: -$9.33 million | Fiscal year 2017: -$9.60 million | Fiscal year 2016: -$8.86 million | Fiscal year 2015: -$7.06 million | Fiscal year 2014: -$8.67 million | Fiscal year 2013: -$6.59 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: